![Pei Lan Chu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pei Lan Chu
Financieel Directeur/CFO bij
SYNERGY SCIENTECH CORP.
Profiel
Pei Lan Chu is currently the Chief Financial Officer & Deputy General Manager at SYNergy ScienTech Corp.
Prior to this, he worked as the Investment Relations Officer at Tanvex BioPharma, Inc. from 2015 to 2019.
Before that, he was the Director-Biotech Section at President International Development Corp.
Mr. Chu holds an MBA from National Sun Yat-Sen University.
Actieve functies van Pei Lan Chu
| Bedrijven | Functie | Begin |
|---|---|---|
| SYNERGY SCIENTECH CORP. | Financieel Directeur/CFO | 01-07-2019 |
Eerdere bekende functies van Pei Lan Chu
| Bedrijven | Functie | Einde |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Investor Relations Contact | - |
President International Development Corp.
 President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Corporate Officer/Principal | - |
Opleiding van Pei Lan Chu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
National Sun Yat-Sen University
 National Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SYNergy ScienTech Corp.
 SYNergy ScienTech Corp. Electrical ProductsProducer Manufacturing Manufactures rechargeable lithium-ion and lithium-ion polymer batteries | Producer Manufacturing |
President International Development Corp.
President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Finance |
Tanvex BioPharma, Inc.
 Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer | Health Technology |
